Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Accolade

Marc Andreessen and OpenAI cofounder back a new frontier tech fund

Casey Caruso thinks that investors who deeply understand technology will win.

Fortune

One of the largest blockchain fund of funds has raised over $135 million across two new vehicles

Accolade has invested in top crypto venture firms from a16z to Haun.

Fortune

After 32 years, the 1992 open-world space game that helped inspire Mass Effect is getting a proper sequel

Free Stars: Children of Infinity is Star Control 3 in all but name, and it managed to smash a $100,000 Kickstarter goal in under 3 hours

GamesRadar

From analysis to the latest developments in health,
read the most diverse news in one place.

Atari buys up over 100 'groundbreaking and award-winning' games from the '80s and '90s and says 'many' will be re-released

Has the OG still got game?

PC Gamer

Bubsy the Bobcat creator & Bend studio co-founder Mike Berlyn dies at 73

The programmer, designer and writer had worked in games since the early 1980s.

PC Gamer

Total lightweight: Australians quick to pick up new flat-pack wine bottles

Backpack friendly, energy-efficient wine bottles are proving a hit with Australian consumers, but premium producers aren’t fully sold on PET packaging

The Guardian - AU

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022

Upgrades

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Riverland growers asked to not deliver grapes for 2023 wine vintage

Wine prices have plunged due to an oversupply in the country and now growers are being offered financial incentives to switch varieties or mothball their vines. Some, however, are simply ripping their vines out of the ground.

ABC News

Here's Why Accolade Shares Are Trading Higher Today

Needham analyst Ryan MacDonald reiterated a Buy rating on Accolade, Inc (NASDAQ:ACCD) with a price target of $12. Following a problematic 4QF22, he noted that Accolade bounced back nicely in 1QF23 as the company beat management's initial outlook for FY23 revenue and adjusted EBITDA. While early in the selling season, ACCD won more new business in 1QF23 than…

Benzinga

10 Analysts Have This to Say About Accolade

Over the past 3 months, 10 analysts have published their opinion on Accolade (NASDAQ:ACCD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Accolade Shares Slip After Q1 Results, Guides Q2 Revenue Below Consensus

Accolade Inc (NASDAQ:ACCD) reported first-quarter revenue growth of 44% year-over-year to $85.5 million, beating the consensus of $81.97 million. EPS was $(4.92), compared to $(0.84) in 1Q22. Adjusted gross profit increased by 63% Y/Y to $39 million, and margin expanded by 545 bps to 45.6%. Adjusted EBITDA loss widened to $(15.4) million…

Benzinga

Earnings Preview For Accolade

Accolade (NASDAQ:ACCD) is set to give its latest quarterly earnings report on Thursday, 2022-06-30. Here's what investors need to know before the announcement. Analysts estimate that Accolade will report an earnings per share (EPS) of $-0.66.

Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga

Analyzing Accolade's Short Interest

Accolade's (NASDAQ:ACCD) short percent of float has fallen 9.9% since its last report. The company recently reported that it has 4.30 million shares sold short, which is 7.74% of all regular shares that are available for trading.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022

Upgrades

Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga

Why Are Accolade Shares Down Over 40% Today

Accolade Inc (NASDAQ:ACCD) shares plunged almost 50% after disappointing Q4 FY22 earnings and FY23 guidance. Q4 FY22 revenue increased 58% Y/Y to $93.8 million, beating the consensus of $91.57 million. The company reported a wider net loss of $(34.56) million compared to $(4.73) million a year ago. EPS loss came at $(0.51)…

Benzinga

Analyst Ratings for Accolade

Analysts have provided the following ratings for Accolade (NASDAQ:ACCD) within the last quarter:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 29, 2022

Upgrades

Benzinga

Expert Ratings for Accolade

Within the last quarter, Accolade (NASDAQ:ACCD) has observed the following analyst ratings:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022

Upgrades

Newcastle Herald

Meet the winemaking ladies leading by example

The Fabulous Ladies' Wine Society's campaign to increase Australian wine industry gender diversity.

Benzinga

What 5 Analyst Ratings Have To Say About Accolade

Accolade (NASDAQ:ACCD) has observed the following analyst ratings within the last quarter:

Benzinga

Analyst Ratings For Accolade

Over the past 3 months, 5 analysts have published their opinion on Accolade (NASDAQ:ACCD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.